Clinical Trials Directory

Trials / Sponsors / Chongqing Claruvis Pharmaceutical Co., Ltd.

Chongqing Claruvis Pharmaceutical Co., Ltd.

Industry · 6 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb
Upper Limb Spasticity
Phase 32026-03-27
RecruitingA Study to Investigate the Safety and Efficacy of YY003 in Adults with Moderate to Severe Glabellar Lines
Moderate to Severe Glabellar Lines
Phase 22025-01-09
RecruitingA Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Sp
Upper Limb Spasticity
Phase 2 / Phase 32024-09-14
Active Not RecruitingA Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injectio
Moderate to Severe Glabellar Lines
Phase 32024-03-19
CompletedA Phase III Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type A for Injection in t
Moderate to Severe Glabellar Lines
Phase 32023-12-28
CompletedA Phase I/II Study of Recombinant Botulinum Toxin Type A for the Treatment of Moderate to Severe Glabellar Lin
Moderate to Severe Glabellar Lines
Phase 1 / Phase 22022-03-22